Bank of India Manufacturing and Infrastructure Fund
The scheme seeks long term capital appreciation through a portfolio of predominantly equity and equity related securities of companies engaged in manufacturing and infrastructure and related sectors.
Growthvine rating: 4/5 — ranked #17 of 84 in category.
Fund basics
| Category | Equity: Sectoral |
|---|
| NAV | ₹67.44 (as of 2026-08-21) |
|---|
| AUM | ₹837 Cr |
|---|
| Expense ratio | 1.96% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nitin Gosar |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 3 months |
|---|
Performance & risk
| 5-year annualised return | 20.24% |
|---|
| Sharpe ratio | 0.89 |
|---|
| Standard deviation | 18.04% |
|---|
| Max drawdown | -47.37% |
|---|
| Alpha | 6.08 |
|---|
| Beta | 0.61 |
|---|
Over 5 years, captured 111.4% of NIFTY Financial Services's upside and 62.4% of its downside.
Market cap allocation
| Large cap | 37.6% |
|---|
| Mid cap | 29.7% |
|---|
| Small cap | 32.7% |
|---|
Concentration
| Top 5 holdings | 26.8% |
|---|
| Top 10 holdings | 43.1% |
|---|
| Total holdings | 53 |
|---|
Top holdings
- Reliance Industries Ltd — 7.9%
- Larsen & Toubro Limited — 5.6%
- TREPS — 5.4%
- NTPC Limited — 5.3%
- ITC Ltd — 4.2%
- Dixon Technologies (India) Limited — 3.9%
- Bharti Airtel Ltd. — 3.8%
- PETRONET LNG LTD. — 3.5%
- Aurobindo Pharma Ltd. — 3.5%
- Stylam Industries Limited — 2.9%
Top sectors
- Pharma & Biotech — 13.0%
- Construction — 11.5%
- Automobile — 8.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 13.4% | Q1 (Top) | #18 of 76 |
| 2025 | 7.8% | Q2 | #22 of 69 |
| 2024 | 25.7% | Q2 | #28 of 58 |
| 2023 | 44.7% | Q1 (Top) | #10 of 48 |
| 2022 | 3.3% | Q3 | #29 of 46 |